Clinical Research Directory
Browse clinical research sites, groups, and studies.
Melatonin Versus Placebo for Bipolar Disorder
Sponsor: Lars Vedel Kessing
Summary
The objective with this study is to conduct a 6-month RCT comparing effects of add-on melatonin versus add-on placebo on mood stabilisation and other critical patient outcomes in patients with BD and to test whether principal effects are antimanic, antidepressant and/or prophylactic against relapse
Official title: Melatonin Versus Placebo for Bipolar Disorder - a Double Blinded Randomised Controlled Trial
Key Details
Gender
All
Age Range
18 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
200
Start Date
2026-03
Completion Date
2028-06
Last Updated
2026-03-16
Healthy Volunteers
No
Conditions
Interventions
Melatonin
Oral: Melatonin capsule 6 mg, 1 capsule/day
Placebo
Oral Placebo capsule, 1 capsule/day
Locations (1)
Mental Health Center Copenhagen, Copenhagen Affective Research Center (CADIC)
Frederiksberg, Denmark